Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Fibrinolysis Resistance in Infection and Trauma

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Blood coagulation disorders are often seen in critically ill patients e.g. with severe infection or following extensive injury, that can lead to life threatening events as a result of excessive blood clot formation leading to organ failure. This study aims to use Viscoelastic Testing (VET) technology to detect patients at risk of excessive blood blot formation at the bedside, test new blood coagulation drugs, and guide life-saving use of blood modifying treatments.

Who May Be Eligible (Plain English)

Sepsis/Septic shock Who May Qualify: - Admission to ICU, needing at least one organ supportand principally for the management of clinically suspected Sepsis or Septic shock according to Spesis-3 criteria (including SARS-COV-2) - Expected to remain in ICU and survive beyond the day after tomorrow Sepsis Who Should NOT Join This Trial: - On oral anticoagulant/antiplatelet therapy - Not for full, active ICU support - Death is deemed inevitable within 24 hrs Trauma Who May Qualify: - Trauma is the principal diagnosis on ICU admission - Expected to remain in ICU and survive beyond the day after tomorrow - Receiving respiratory support at the time of ICU admission - high-flow nasal prongs, non-invasive or invasive ventilation - Already received, or considered at risk of needing a blood product transfusion within 24 hrs of injury Trauma Who Should NOT Join This Trial: - Nursing home resident - Unsurvivable head injury - Not for full, active ICU support - Death is deemed inevitable within 24 hrs Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Sepsis/Septic shock Inclusion Criteria: * Admission to ICU, needing at least one organ supportand principally for the management of clinically suspected Sepsis or Septic shock according to Spesis-3 criteria (including SARS-COV-2) * Expected to remain in ICU and survive beyond the day after tomorrow Sepsis Exclusion Criteria: * On oral anticoagulant/antiplatelet therapy * Not for full, active ICU support * Death is deemed inevitable within 24 hrs Trauma Inclusion Criteria: * Trauma is the principal diagnosis on ICU admission * Expected to remain in ICU and survive beyond the day after tomorrow * Receiving respiratory support at the time of ICU admission - high-flow nasal prongs, non-invasive or invasive ventilation * Already received, or considered at risk of needing a blood product transfusion within 24 hrs of injury Trauma Exclusion Criteria: * Nursing home resident * Unsurvivable head injury * Not for full, active ICU support * Death is deemed inevitable within 24 hrs

Treatments Being Tested

DIAGNOSTIC_TEST

Viscoelastometric assessment of fibrinolysis

Viscoelastometric assessment of whole blood fibrinolysis using supplemental tissue plasminogen activator (tPA) and other agents ex vivo to influence fibrinolysis capacity.

Locations (4)

The Canberra hospital (ICU)
Canberra, Australian Capital Territory, Australia
Liverpool Hospital (ICU)
Liverpool, New South Wales, Australia
Macquarie University Hospital (ICU)
Macquarie, New South Wales, Australia
Royal North Shore Hospital (ICU)
St Leonards, New South Wales, Australia